Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Horizon Pharma, Inc. (HZNP)  
$28.30 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 211,410,000
Market Cap: 5.98(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $28.3 - $28.3
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Horizon Therapeutics is focused on researching, developing and commercializing medicines that address the needs for people with rare and rheumatic diseases. Co. has two segments, the orphan segment and the inflammation segment. The Orphan segment includes: TEPEZZA, which is indicated for the treatment of thyroid eye diseas; KRYSTEXXA, which is indicated for the treatment of uncontrolled gout; and PROCYSBI, which is indicated for nephropathic cystinosis. The Inflammation segment includes: PENNSAID 2% w/w, which is indicated for the treatment of pain of osteoarthritis (OA), of the knee(s); and DUEXIS, which is indicated for the relief of signs and symptoms of rheumatoid arthritis and OA.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-12-29 2024-09-27 2024-03-29 2023-03-30

   
Records found: 914
  Page 1 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Witz Pascale Director   –       •      –    2023-10-06 4 D $116.50 $2,362,504 I/I (20,279) 0     -
   Witz Pascale Director   –       •      –    2023-10-06 4 D $116.50 $2,990,788 D/D (25,672) 0     -
   Santini Gino Director   –       •      –    2023-10-06 4 D $116.50 $2,173,308 I/I (18,655) 0     -
   Santini Gino Director   –       •      –    2023-10-06 4 D $116.50 $11,761,724 D/D (100,959) 0     -
   Clayton Sean M. EVP, General Counsel   •       –      –    2023-10-06 4 D $116.50 $86,793 I/I (745) 0     -
   Clayton Sean M. EVP, General Counsel   •       –      –    2023-10-06 4 D $116.50 $891,808 D/D (7,655) 0     -
   Cox Aaron EVP, Chief Financial Officer   •       –      –    2023-10-06 4 D $116.50 $64,774 D/D (556) 0     -
   Pasternak Andy EVP, Chief Strategy Officer   •       –      –    2023-10-06 4 D $116.50 $6,563,377 D/D (56,338) 0     -
   Sherman Jeffrey W EVP and Chief Medical Officer   •       –      –    2023-10-06 4 D $116.50 $27,040,116 I/I (232,104) 0     -
   Sherman Jeffrey W EVP and Chief Medical Officer   •       –      –    2023-10-06 4 D $116.50 $309,308 D/D (2,655) 0     -
   Thompson Elizabeth H.z. EVP, Research & Development   •       –      –    2023-10-06 4 D $116.50 $1,697,988 D/D (14,575) 0     -
   Mahony Susan Director   –       •      –    2023-10-06 4 D $116.50 $1,084,149 I/I (9,306) 0     -
   Mahony Susan Director   –       •      –    2023-10-06 4 D $116.50 $1,088,693 D/D (9,345) 0     -
   Daniel William F Director   –       •      –    2023-10-06 4 D $116.50 $5,553,555 I/I (47,670) 0     -
   Daniel William F Director   –       •      –    2023-10-06 4 D $116.50 $3,718,098 D/D (31,915) 0     -
   Watkins Thomas Director   –       •      –    2023-10-06 4 D $116.50 $7,683,525 I/I (65,953) 0     -
   Watkins Thomas Director   –       •      –    2023-10-06 4 D $116.50 $12,867,076 D/D (110,447) 0     -
   Grey Michael G Director   –       •      –    2023-10-06 4 D $116.50 $6,760,612 I/I (58,031) 0     -
   Grey Michael G Director   –       •      –    2023-10-06 4 D $116.50 $4,585,557 D/D (39,361) 0     -
   Walbert Timothy P Chairman, President and CEO   •       •      –    2023-10-06 4 D $116.50 $30,053,971 I/I (257,974) 0     -
   Walbert Timothy P Chairman, President and CEO   •       •      –    2023-10-06 4 D $116.50 $71,853,938 D/D (616,772) 0     -
   Desjardin Michael A. EVP, Technical Operations   •       –      –    2023-10-06 4 D $116.50 $14,776,627 D/D (126,838) 0     -
   Shannon James Samuel Director   –       •      –    2023-10-06 4 D $116.50 $2,753,827 I/I (23,638) 0     -
   Shannon James Samuel Director   –       •      –    2023-10-06 4 D $116.50 $3,862,674 D/D (33,156) 0     -
   Mcilvenny Patrick Chief Accounting Officer   •       –      –    2023-10-06 4 D $116.50 $800,821 D/D (6,874) 0     -
  914 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us